Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03337399 · ClinicalTrials.gov registry record · NA

Stepped Palliative Care Versus Early Integrated Palliative Care in Patients With Advanced Lung Cancer

A NA study of Lung Cancer, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
507
Enrollment target
3
Study locations

NCT03337399: Completed NA study of Lung Cancer, sponsored by Massachusetts General Hospital.

NCT03337399 is a NA study of Lung Cancer that has completed, run by Massachusetts General Hospital. The registered enrollment target is 507 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (46% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03337399, a NA study of Lung Cancer, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
507 participants
Enrollment target
3
Study locations

Study Summary

This research study is evaluating ways to provide palliative care to patients who have recently been diagnosed with lung cancer

Conditions Studied

Lung Cancer

Interventions

  • OTHER Stepped PC
  • OTHER Early Integrated PC

Study Locations (3)

Massachusetts

  • Massachusetts General Hospital - Boston

North Carolina

  • Duke University - Durham

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 507 participants
Start Date 2018-02-01
Est. Completion 2023-12-31
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03337399

The ClinicalTrials.gov registry entry for NCT03337399 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 507 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (46% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which Stepped PC is the first listed.

NCT03337399 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Massachusetts, North Carolina, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03337399 about?

NCT03337399 is a clinical study titled "Stepped Palliative Care Versus Early Integrated Palliative Care in Patients With Advanced Lung Cancer". This research study is evaluating ways to provide palliative care to patients who have recently been diagnosed with lung cancer

What is the current status of trial NCT03337399?

This trial is currently completed. It is a NA study. The enrollment target is 507 participants. The study started on 2018-02-01. Estimated completion is 2023-12-31.

What conditions does trial NCT03337399 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT03337399?

The interventions under investigation include: Stepped PC (OTHER), Early Integrated PC (OTHER).

Who is sponsoring clinical trial NCT03337399?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03337399 being conducted?

This trial has 3 study locations across Massachusetts, North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lung Cancer

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.